The Oncosearch | Oncotarget

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation Research Paper

Hyung Kwon Byeon, Hwi Jung Na, Yeon Ju Yang, Sooah Ko, Sun Och Yoon, Minhee Ku, Jaemoon Yang, Jae Wook Kim, Myung Jin Ban, Ji-Hoon Kim, Da Hee Kim, Jung Min Kim, Eun Chang Choi, Chang-Hoon Kim, Joo-Heon Yoon, Yoon Woo Koh

Published Nov 21, 2016 · Vol. 8, No. 1 · pp. 596-609

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer Research Paper

Rebecca C. Arend, Angelina I. LondoÃ±o-Joshi, Abhishek Gangrade, Ashwini A. Katre, Chandrika Kurpad, Yonghe Li, Rajeev S. Samant, Pui-Kai Li, Charles N. Landen, Eddy S. Yang, Bertha Hidalgo, Ronald D. Alvarez, John Michael Straughn, Andres Forero, Donald J. Buchsbaum

Published Nov 19, 2016 · Vol. 7, No. 52 · pp. 86803-86815

The role of p53 in cancer drug resistance and targeted chemotherapy Review

Karin Hientz, AndrÃ© Mohr, Dipita Bhakta-Guha, Thomas Efferth

Published Nov 19, 2016 · Vol. 8, No. 5 · pp. 8921-8946

Targeting tachykinin receptors in neuroblastoma Research Paper

Anton G. Henssen, Andrea Odersky, Annabell Szymansky, Marleen Seiler, Kristina Althoff, Anneleen Beckers, Frank Speleman, Simon SchÃ¤fers, Katleen De Preter, Kathy Astrahanseff, Joachim Struck, Alexander Schramm, Angelika Eggert, Andreas Bergmann, Johannes H. Schulte

Published Nov 18, 2016 · Vol. 8, No. 1 · pp. 430-443

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration Research Paper

Vida Farsam, Abhijit Basu, Martina Gatzka, Nicolai Treiber, Lars A. Schneider, Medhanie A. Mulaw, Tanja Lucas, Stefan Kochanek, Reinhard Dummer, Mitchell P. Levesque, Meinhard Wlaschek, Karin Scharffetter-Kochanek

Published Nov 18, 2016 · Vol. 7, No. 50 · pp. 83554-83569

Association of high microvessel Î±_vÎ²₃ and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126 Research Paper

Anat Erdreich-Epstein, Alok R. Singh, Shweta Joshi, Francisco M. Vega, Pinzheng Guo, Jingying Xu, Susan Groshen, Wei Ye, Melissa Millard, Mihaela Campan, Guillermo Morales, Joseph R. Garlich, Peter W. Laird, Robert C. Seeger, Hiroyuki Shimada, Donald L. Durden

Published Nov 18, 2016 · Vol. 8, No. 32 · pp. 52193-52210

Pharmacological agonists for more-targeted CNS radio-pharmaceuticals Editorial

Luc Zimmer

Published Nov 16, 2016 · Vol. 7, No. 49 · pp. 80111-80112

Patient-derived glioblastoma stem cells respond differentially to targeted therapies Research Paper

Pratik Kanabur, Sujuan Guo, Cara M. Rodgers, Gary R. Simonds, Deborah F. Kelly, Robert G. Gourdie, Zhi Sheng, Zhi Sheng

Published Nov 16, 2016 · Vol. 7, No. 52 · pp. 86406-86419

Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma Research Paper

Matthew J. Martin, Cath Eberlein, Molly Taylor, Susan Ashton, David Robinson, Darren Cross

Published Nov 16, 2016 · Vol. 7, No. 52 · pp. 86313-86325

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy Clinical Research Papers

Rossana Berardi, Matteo Santoni, Thomas Newsom-Davis, Miriam Caramanti, Silvia Rinaldi, Michela Tiberi, Francesca Morgese, Mariangela Torniai, Mirco Pistelli, Azzurra Onofri, Marc Bower, Stefano Cascinu

Published Nov 15, 2016 · Vol. 8, No. 14 · pp. 23871-23879

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer Research Paper

Evelyn Kidess-Sigal, Haiyan E. Liu, Melanie M. Triboulet, James Che, Vishnu C. Ramani, Brendan C. Visser, George A. Poultsides, Teri A. Longacre, Andre Marziali, Valentina Vysotskaia, Matthew Wiggin, Kyra Heirich, Violet Hanft, Ulrich Keilholz, Ingeborg Tinhofer, Jeffrey A. Norton, Mark Lee, Elodie Sollier-Christen, Stefanie S. Jeffrey

Published Nov 15, 2016 · Vol. 7, No. 51 · pp. 85349-85364

Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin Research Paper

Anna V. Gaponova, Alexander Y. Deneka, Tim N. Beck, Hanqing Liu, Gregory Andrianov, Anna S. Nikonova, Emmanuelle Nicolas, Margret B. Einarson, Erica A. Golemis, Ilya G. Serebriiskii

Published Nov 15, 2016 · Vol. 8, No. 12 · pp. 19156-19171

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR Research Paper

Nneha Sakre, Gary Wildey, Mohadese Behtaj, Adam Kresak, Michael Yang, Pingfu Fu, Afshin Dowlati

Published Nov 15, 2016 · Vol. 8, No. 4 · pp. 5992-6002

Targeted next generation sequencing identifies two novel mutations in SEPN1 in rigid spine muscular dystrophy 1 Research Paper

Yi Dai, Shengran Liang, Yan Huang, Lin Chen, Santasree Banerjee

Published Nov 14, 2016 · Vol. 7, No. 51 · pp. 83843-83849

Bevacizumab in ovarian cancer: A critical review of phase III studies Review

Luigi Rossi, Monica Verrico, Eleonora Zaccarelli, Anselmo Papa, Maria Colonna, Martina Strudel, Patrizia Vici, Vincenzo Bianco, Federica Tomao

Published Nov 11, 2016 · Vol. 8, No. 7 · pp. 12389-12405

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group Research Paper

StÃ©phane Oudard, Reza Elaidi, Mara Brizard, CÃ©line Le Rest, ValÃ©rie Caillet, Sophie Deveaux, GÃ©rard Benoit, Jean-Michel CorrÃ©as, Farida Benoudiba, Philippe David, Alain Gaudric, Pascal Hammel, Dominique Joly, Marc Olivier Timsit, Arnaud MÃ©jean, StÃ©phane Richard

Published Nov 11, 2016 · Vol. 7, No. 51 · pp. 85306-85317

Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland Research Paper

Lora E. Bakeeva, Chupalav M. Eldarov, Irina M. Vangely, Nataliya G. Kolosova, Valeriya B. Vays

Published Nov 11, 2016 · Vol. 7, No. 49 · pp. 80208-80222

Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? Review

Kiruthikah Thillai, Hoyin Lam, Debashis Sarker, Claire M. Wells

Published Nov 11, 2016 · Vol. 8, No. 8 · pp. 14173-14191

TLE1 function and therapeutic potential in cancer Review

Da Yuan, Xue Yang, Zhenpeng Yuan, Yanqing Zhao, Junchao Guo

Published Nov 10, 2016 · Vol. 8, No. 9 · pp. 15971-15976

Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro Research Paper

Jing Ma, Ming Shen, Chang Song Xu, Ying Sun, You Rong Duan, Lian Fang Du

Published Nov 9, 2016 · Vol. 7, No. 48 · pp. 80008-80018

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation Research Paper

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer Research Paper

The role of p53 in cancer drug resistance and targeted chemotherapy Review

Targeting tachykinin receptors in neuroblastoma Research Paper

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration Research Paper

Association of high microvessel Î±_vÎ²₃ and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126 Research Paper

Pharmacological agonists for more-targeted CNS radio-pharmaceuticals Editorial

Patient-derived glioblastoma stem cells respond differentially to targeted therapies Research Paper

Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma Research Paper

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy Clinical Research Papers

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer Research Paper

Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin Research Paper

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR Research Paper

Targeted next generation sequencing identifies two novel mutations in SEPN1 in rigid spine muscular dystrophy 1 Research Paper

Bevacizumab in ovarian cancer: A critical review of phase III studies Review

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group Research Paper

Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland Research Paper

Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? Review

TLE1 function and therapeutic potential in cancer Review

Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation Research Paper

Niclosamide and its analogs are potent inhibitors of Wnt/β-catenin, mTOR and STAT3 signaling in ovarian cancer Research Paper

The role of p53 in cancer drug resistance and targeted chemotherapy Review

Targeting tachykinin receptors in neuroblastoma Research Paper

Senescent fibroblast-derived Chemerin promotes squamous cell carcinoma migration Research Paper

Association of high microvessel Î±vÎ²3 and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126 Research Paper

Pharmacological agonists for more-targeted CNS radio-pharmaceuticals Editorial

Patient-derived glioblastoma stem cells respond differentially to targeted therapies Research Paper

Inhibition of oxidative phosphorylation suppresses the development of osimertinib resistance in a preclinical model of EGFR-driven lung adenocarcinoma Research Paper

Hyponatremia normalization as an independent prognostic factor in patients with advanced non-small cell lung cancer treated with first-line therapy Clinical Research Papers

Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer Research Paper

Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin Research Paper

RICTOR amplification identifies a subgroup in small cell lung cancer and predicts response to drugs targeting mTOR Research Paper

Targeted next generation sequencing identifies two novel mutations in SEPN1 in rigid spine muscular dystrophy 1 Research Paper

Bevacizumab in ovarian cancer: A critical review of phase III studies Review

Sunitinib for the treatment of benign and malignant neoplasms from von Hippel-Lindau disease: A single-arm, prospective phase II clinical study from the PREDIR group Research Paper

Mitochondria-targeted antioxidant SkQ1 reduces age-related alterations in the ultrastructure of the lacrimal gland Research Paper

Deciphering the link between PI3K and PAK: An opportunity to target key pathways in pancreatic cancer? Review

TLE1 function and therapeutic potential in cancer Review

Biodegradable double-targeted PTX-mPEG-PLGA nanoparticles for ultrasound contrast enhanced imaging and antitumor therapy in vitro Research Paper

Association of high microvessel Î±_vÎ²₃ and low PTEN with poor outcome in stage 3 neuroblastoma: rationale for using first in class dual PI3K/BRD4 inhibitor, SF1126 Research Paper